Cita APA (7a ed.)
Yu, R., Gunawan, R., Li, Z., Mittleman, R., Mahmood, A., Grundy, J., . . . Wang, Y. (2016). No effect on QT intervals of mipomersen, a 2′- O-methoxyethyl modified antisense oligonucleotide targeting ApoB-100 mRNA, in a phase I dose escalation placebo-controlled study, and confirmed by a thorough QT (tQT) study, in healthy subjects. European Journal of Clinical Pharmacology, 72(3), 267-276.
Cita Chicago Style (17a ed.)
Yu, Rosie, Rudy Gunawan, Zhaoyang Li, Robert Mittleman, Asif Mahmood, John Grundy, Walter Singleton, Richard Geary, y Yanfeng Wang. "No Effect on QT Intervals of Mipomersen, a 2′- O-methoxyethyl Modified Antisense Oligonucleotide Targeting ApoB-100 MRNA, in a Phase I Dose Escalation Placebo-controlled Study, and Confirmed by a Thorough QT (tQT) Study, in Healthy Subjects." European Journal of Clinical Pharmacology 72, no. 3 (2016): 267-276.
Cita MLA (9a ed.)
Yu, Rosie, et al. "No Effect on QT Intervals of Mipomersen, a 2′- O-methoxyethyl Modified Antisense Oligonucleotide Targeting ApoB-100 MRNA, in a Phase I Dose Escalation Placebo-controlled Study, and Confirmed by a Thorough QT (tQT) Study, in Healthy Subjects." European Journal of Clinical Pharmacology, vol. 72, no. 3, 2016, pp. 267-276.
Precaución: Estas citas no son 100% exactas.